These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 20605119

  • 1. [Immunoglobulin in suspected Kawasaki disease].
    García Soblechero E, Gómez Santos E, Domínguez Quintero ML, González Vila L.
    An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119
    [No Abstract] [Full Text] [Related]

  • 2. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC, Vincenti M, Darras JP, Lalande M, Rodière M, Filleron A.
    Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
    [Abstract] [Full Text] [Related]

  • 3. External validation of a scoring system to predict resistance to intravenous immunoglobulin.
    Kobayashi T, Inoue Y, Tamura K, Morikawa A, Kobayashi T.
    J Pediatr; 2007 Apr; 150(4):e37; author reply e38. PubMed ID: 17382098
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of Kawasaki disease.
    Taddio A, Rosé CD.
    N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract] [Full Text] [Related]

  • 5. Non-classical Kawasaki disease in a 2 month old infant.
    Hartmann I, Weiss K, Bistritzer T, Baram S, Goldman M.
    Isr Med Assoc J; 2006 Aug 28; 8(8):581-2. PubMed ID: 16958253
    [No Abstract] [Full Text] [Related]

  • 6. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.
    Pagnini I, Marino A, Simonini G, Cimaz R.
    Clin Exp Rheumatol; 2012 Aug 28; 30(1 Suppl 70):S170. PubMed ID: 22410254
    [No Abstract] [Full Text] [Related]

  • 7. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
    Lee KY, Oh JH, Han JW, Lee JS, Lee BC.
    Eur J Pediatr; 2005 Jul 28; 164(7):451-2. PubMed ID: 15782294
    [No Abstract] [Full Text] [Related]

  • 8. Kawasaki disease.
    Harnden A, Tulloh R, Burgner D.
    BMJ; 2014 Sep 17; 349():g5336. PubMed ID: 25230954
    [No Abstract] [Full Text] [Related]

  • 9. [Current state of diagnosis and treatment of incomplete Kawasaki disease].
    Zhang QY, Du JB.
    Zhonghua Er Ke Za Zhi; 2006 May 17; 44(5):339-41. PubMed ID: 16780709
    [No Abstract] [Full Text] [Related]

  • 10. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
    Wang HW.
    Zhonghua Er Ke Za Zhi; 2006 May 17; 44(5):337-8. PubMed ID: 16780708
    [No Abstract] [Full Text] [Related]

  • 11. Acute renal failure and febrile rash--infectious or not? Adult Kawasaki disease (KD).
    El Karoui K, Servais A, Fadel F, Jablonski M, Fakhouri F, Lesavre P, Hummel A.
    Nephrol Dial Transplant; 2007 Mar 17; 22(3):949-51. PubMed ID: 17210597
    [No Abstract] [Full Text] [Related]

  • 12. Lessons from Kawasaki disease: all brands of IVIG are not equal.
    Stiehm ER.
    J Pediatr; 2006 Jan 17; 148(1):6-8. PubMed ID: 16423589
    [No Abstract] [Full Text] [Related]

  • 13. Acute cholestasis: atypical onset of Kawasaki disease.
    Valentini P, Ausili E, Schiavino A, Angelone DF, Focarelli B, De Rosa G, Ranno O.
    Dig Liver Dis; 2008 Jul 17; 40(7):582-4. PubMed ID: 18055284
    [Abstract] [Full Text] [Related]

  • 14. At the heart of the fever: Kawasaki disease.
    McLellan MC, Baker AL.
    Am J Nurs; 2011 Jun 17; 111(6):57-63. PubMed ID: 21613923
    [No Abstract] [Full Text] [Related]

  • 15. Resistant Kawasaki disease treated with anti-CD20.
    Sauvaget E, Bonello B, David M, Chabrol B, Dubus JC, Bosdure E.
    J Pediatr; 2012 May 17; 160(5):875-6. PubMed ID: 22341587
    [Abstract] [Full Text] [Related]

  • 16. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G, Pardeo M, Rigante D.
    Eur Rev Med Pharmacol Sci; 2007 May 17; 11(5):301-8. PubMed ID: 18074939
    [Abstract] [Full Text] [Related]

  • 17. Marked pleural effusion after i.v. immunoglobulin therapy for Kawasaki disease.
    Koizumi K, Hoshiai M, Toda T, Nakane T, Sugita K.
    Pediatr Int; 2018 Mar 17; 60(3):307-308. PubMed ID: 29480538
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May 17; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 19. Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease.
    Chin CY.
    Pediatr Neonatol; 2024 Sep 17; 65(5):417-418. PubMed ID: 39122627
    [No Abstract] [Full Text] [Related]

  • 20. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S, Doré PC, Sewell WA.
    Pediatr Allergy Immunol; 2008 Mar 17; 19(2):186-7. PubMed ID: 18257907
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.